"In light of the strong demand for our products we are expanding our facilities and our investments in research and development," continued the Bayer CropScience CEO. The company has embarked on an investment program in 2013 that will see capital expenditures of € 2.4 billion EUR through 2016: Out of this, € 1.3 billion will be spent in Europe, with € 800 million being planned for Germany alone.